Skip to main content
Clinical Trials/NCT02737124
NCT02737124
Withdrawn
Phase 3

Prospective Randomized Control Trial Assessing Effects of Pre-Operative Acetaminophen in Isolated Meniscectomy Patients

NYU Langone Health1 site in 1 countryFebruary 16, 2017

Overview

Phase
Phase 3
Intervention
Acetaminophen
Conditions
Post Operative Pain
Sponsor
NYU Langone Health
Locations
1
Primary Endpoint
Pain using the visual analogue scale
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

Patients that are to undergo isolated meniscectomy will be randomized to 2 cohorts: one will take the FDA recommended dose of acetominophen (1000mg) 24hrs before surgery, one will be given a similarly looking placebo pill. A multitude of post-op variables will be included, mainly pain scores and morphine equivalent doses at different time points.

Registry
clinicaltrials.gov
Start Date
February 16, 2017
End Date
March 19, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Must be at least 18 years of age
  • ASA Class I-II
  • Patients scheduled for meniscectomy

Exclusion Criteria

  • Contraindication to acetaminophen (hypersensitivity, extensive alcohol history, liver disease, actively breastfeeding)
  • Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)
  • Younger than 18 years of age or older than 65
  • Any patient considered a vulnerable subject
  • Patients on pain medication prior to surgery

Arms & Interventions

1000 Mg Acetaminophen

Acetaminophen will be given 24 hours before surgery

Intervention: Acetaminophen

Placebo

A sugar pill will be given 24 hours before the scheduled surgery.

Intervention: Placebo

Outcomes

Primary Outcomes

Pain using the visual analogue scale

Time Frame: 7 Days

The visual analogue scale is a scale with a line from 0 on one side and 100 on the other where the patient is asked to mark where they believe their pain is.

Narcotic Use

Time Frame: 7 Days

Total morphine-equivalent dose consumption during immediate post-op, phase 1 recover, phase II recovery, at 2 days, and at 7 days will also be recorded.

Measure of time to discharge from the PACU

Time Frame: 7 Days

Time to discharge from the PACU

Morphine-equivalent dose consumption

Time Frame: 7 days

Total morphine-equivalent dose consumption during immediate post-op, phase 1 recover, phase II recovery, at 2 days, and at 7 days

Measure of time to discharge from hospital

Time Frame: 7 Days

Time to discharge from the hospital

Study Sites (1)

Loading locations...

Similar Trials